Diamorphine 5mg injections, Microgynon 30 and Ovranette tablets – Supply update

Diamorphine 5mg injections, Microgynon 30 and Ovranette tablets – Supply update

May 22, 2019

Supply Update

Diamorphine 5mg injections

Accord and Wockhardt have notified the Department of Health and Social Care (DHSC) and NHS England (NHSE) that they are experiencing issues with the manufacture and availability of Diamorphine 5mg injections. There is an anticipated out of stock period between 27th May 2019 and w/c 5th August 2019. It is expected that there will be sufficient supplies of Diamorphine 10mg injections to support the forecasted use of the 5mg via usual wholesalers.

Please see the communication from DHSC for further information.

Microgynon 30 tablets

Bayer has notified DHSC that Microgynon 30 tablets will be out of stock from late May until w/c 8th July (wholesalers may have residual stock until early June), this is due to capacity constraints at their manufacturing site in Germany. Please see the communication from Bayer and DHSC for further information.

Ovranette tablets 

Pfizer have notified DHSC they will be out of stock of Ovranette tablets from early June until August 2019 due to capacity constraints.

As both Microgynon 30 and Ovranette contain ethinylestradiol 30microgram/levonorgestrel 150microgram there are several alternative suppliers, DHSC has been advised there are sufficient supplies available from certain suppliers to maintain demand throughout the duration of this supply issue. Further details can be found in the DHSC communication.

 



Posted in: ,


More Latest News >